EU collaboration strengthens safety monitoring of medicines

European Commission publishes three-year report on implementation of pharmacovigilance legislation

Closer collaboration between the European Medicines Agency (EMA), the European Commission and the EU Member States, enabled by the new European pharmacovigilance legislation, has enhanced the monitoring of the safety of human medicines throughout their life cycle, for the benefit of patients. This is highlighted in the European Commission report on the pharmacovigilance activities of the European medicines regulatory network published today.

The report describes the activities of the EU system for monitoring and managing the safety of human medicines from the time the new pharmacovigilance legislation came into effect in July 2012, until July 2015.

Read more online
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /